SARS-CoV-2 protease suppresses host immune response by cleaving NEMO
A recent study conducted by a team of US-based scientists has highlighted a novel function of 3C-like protease of severe […]
» Read moreHome »
The severe acute respiratory disorder coronavirus (SARS-CoV-2) virus, the causative agent of COVID-19 disease, is thought to spread from animals […] Patients with primary or secondary immunodeficiency-associated antibody disorders cannot produce antibodies against infective agents. Thus, these individuals are often at […] Scientists worldwide have been working at an unprecedented speed to develop various means to contain the coronavirus disease 2019 (COVID-19) […] The rapid and extensive spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) led to the imposition of severe […] Newly emerging variants of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have contributed to successive waves of the coronavirus […] Even with the rapid production and distribution of safe and effective coronavirus disease 2019 (COVID-19) vaccines, their availability in low-resource […] In December 2020, two mRNA vaccines were approved for use against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Canada, […] Researchers in the United States have conducted a study showing that Moderna’s coronavirus disease 2019 (COVID-19) vaccine provided durable protection […] The sudden outbreak of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has resulted in the ongoing coronavirus disease 2019 (COVID-19) pandemic […]
A study of livestock exposure to the SARS-CoV-2 virus
Analysis of immunodeficient patients granted REGEN-COV under compassionate use COVID-19 program
Invalidation of potential SARS-CoV-2 protease inhibitors
COVID-19 lockdowns and young people's mental health
The impact of SARS-CoV-2 variants on the COVID-19 epidemic in South Africa
Study finds early fluvoxamine treatment among COVID-19 patients reduces hospitalization
Two-dose SARS-CoV-2 vaccine effectiveness against infection and hospitalization in Canada
Moderna’s COVID-19 vaccine provides durable protection against SARS-CoV-2 delta in macaques
Attitudes towards COVID-19 vaccination amongst essential workers
